Skip to content
Film Television Auditions – Lifestyle
Author:
Denovo Biopharma
Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant
June 3, 2026
Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
April 29, 2026